Tardive Dyskinesia caused by neuroleptic drugs Terminated Phase Trials for Sarizotan (DB06454)

Also known as: Neuroleptic-Induced Tardive Dyskinesia / Drug induced subacute dyskinesia / Neuroleptic-induced tardive dyskinesia (disorder)

IndicationStatusPhase
DBCOND0093521 (Tardive Dyskinesia caused by neuroleptic drugs)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00310661
Sarizotan in the Treatment of Neuroleptic-induced Tardive DyskinesiaTreatment